Last reviewed · How we verify
NCT05757778
Split Chest Breast Neurotization
NA trial testing Sensory Nerve Coaptation in Breast Implant; Complications in 6 participants. Participants enrolled and being followed up; not accepting new ones.
7 April 2027
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 8 August 2023 |
| Primary completion | 7 April 2027 |
| Estimated completion | 7 April 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sensory Nerve Coaptation
Conditions studied
- Breast Implant; Complications — all drugs for Breast Implant; Complications →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 99, female only, with Breast Implant; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several members of the scientific community have suggested that breast neurotization can help return nipple sensation to patients undergoing implant-based breast reconstruction. There has been no randomized controlled study assessing the validity of these claims. The goal of this study is to evaluate if performing breast neurotization can help restore or improve return of nipple sensation to patients undergoing implant-based breast reconstruction. This will be a single-blinded, randomized controlled trial where patients undergoing bilateral reconstruction will serve as their own controls by receiving an intervention on one breast but not the other breast.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05757778
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Implant; Complications
Currently open trials in the same condition.
- NCT06414785 — Characterization of Capsule Inflammation in Patients Exposed to Silicone Breast Implants · recruiting
- NCT05899387 — Seroma of the Mammary Gland · NA · recruiting
- NCT06274736 — Safety and Performance of Motiva® Sizers · recruiting
- NCT05736354 — Molecular Mechanisms Associated With Breast Implant Complications · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05757778 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757778.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing